Here are the five deals with the highest price tags so far in 2014.
1. Troy Hills, N.J.-based pharmaceutical company Actavis paid $66 billion to acquire fellow pharmaceutical company Irvine, Calif.-based Allergan, Inc.
2. Minneapolis-based Medtronic, a medical device manufacture, paid $42.9 billion to acquire Dublin-based Covidien.
3. Actavis paid $25 billion to acquire Forest Labs, a pharmaceutical company based in New York City.
4. White House Station, N.J.-based Merck paid $17 billion to acquire Sigma-Aldrich Corp., a life science and technology company based in St. Louis.
5. Basel, Switzerland-based pharmaceutical company Novartis paid $16 billion to acquire Brentford, England- based GlaxoSmithKline’s oncology business.
More articles on healthcare industry transactions:
Boston Medical Center, Tufts begin merger talks
Tenet ends bid to acquire 5 Connecticut hospitals
Breaking down the 5 most interesting hospital M&A deals of the year
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
